Leitlinie „Behandlung der Akne“ - AWMF

013/017 - Behandlung der Akne aktueller Stand: 02/2010
korrigierte Fassung: 10/2011
470. Worret WI, Fluhr JW. [Acne therapy with topical benzoyl peroxide, antibiotics and
azelaic acid]. J Dtsch Dermatol Ges. 2006; 4: 293-300.
471. Kretschmar R, Leuschner F. Investigation on the toxicity of tretinoin administered
systemically to animals. Acta Derm Venereol Suppl (Stockh). 1975; 74: 25-8.
472. van Hoogdalem EJ. Transdermal absorption of topical anti-acne agents in man; review
of clinical pharmacokinetic data. J Eur Acad Dermatol Venereol. 1998; 11 Suppl 1:
S13-9; discussion S28-9.
473. Nau H. Embryotoxicity and teratogenicity of topical retinoic acid. Skin Pharmacol.
1993; 6 Suppl 1: 35-44.
474. Krautheim A, Gollnick H. Transdermal penetration of topical drugs used in the
treatment of acne. Clin Pharmacokinet. 2003; 42: 1287-304.
475. Duran B, Gursoy S, Cetin M, Demirkoprulu N, Demirel Y, Gurelik B. The oral
toxicity of resorcinol during pregnancy: a case report. J Toxicol Clin Toxicol. 2004;
42: 663-6.
476. Thiboutot DM. Overview of acne and its treatment. Cutis. 2008; 81: 3-7.
477. Hale EK, Pomeranz MK. Dermatologic agents during pregnancy and lactation: an
update and clinical review. Int J Dermatol. 2002; 41: 197-203.
478. Koren G, Pastuszak A, Ito S. Drugs in pregnancy. N Engl J Med. 1998; 338: 1128-37.
479. Morsches B, Holzmann H. [Studies on the percutaneous absorption of benzoyl
peroxide (author's transl)]. Arzneimittelforschung. 1982; 32: 298-300.
480. Nacht S, Yeung D, Beasley JN, Jr., Anjo MD, Maibach HI. Benzoyl peroxide:
percutaneous penetration and metabolic disposition. J Am Acad Dermatol. 1981; 4:
31-7.
481. Cunliffe WJ, Gollnick HPF, Orfanos CE. Akne. Hippokrates Verlag, Stuttgart, 1993.
ISBN: 1841844047
482. Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ, Shalita AR,
Thiboutot D. Management of acne: a report from a Global Alliance to Improve
Outcomes in Acne. J Am Acad Dermatol. 2003; 49 Suppl 1: S1-37.
483. Tauber U, Weiss C, Matthes H. Percutaneous absorption of azelaic acid in humans.
Exp Dermatol. 1992; 1: 176-9.
484. Cooper WO, Griffin MR, Arbogast P, Hickson GB, Gautam S, Ray WA. Very early
exposure to erythromycin and infantile hypertrophic pyloric stenosis. Arch Pediatr
Adolesc Med. 2002; 156: 647-50.
485. Weinstein AJ, Gibbs RS, Gallagher M. Placental transfer of clindamycin and
gentamicin in term pregnancy. Am J Obstet Gynecol. 1976; 124: 688-91.
486. McCormack WM, George H, Donner A, Kodgis LF, Alpert S, Lowe EW, Kass EH.
Hepatotoxicity of erythromycin estolate during pregnancy. Antimicrob Agents
Chemother. 1977; 12: 630-5.
487. Gallagher JC, Ismail MA, Aladjem S. Reduced urinary estriol levels with
erythromycin therapy. Obstet Gynecol. 1980; 56: 381-2.
488. Dreno B, Blouin E. [Acne, pregnant women and zinc salts: a literature review]. Ann
Dermatol Venereol. 2008; 135: 27-33.
Seite 135 von 136